Thiazolopyridine

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S106000, C544S111000, C544S125000, C544S127000, C514S231200, C514S233800, C514S299000, C514S301000, C546S112000, C546S114000

Reexamination Certificate

active

10941708

ABSTRACT:
The present invention relates to compounds of formula Iwherein R1and R2are described hereinbelow. These compounds have high affinity to A2Areceptors and good selectivity to A1and A3receptors. These compounds are useful, inter alia, in the treatment of Alzheimer's disease, depression, Parkinson's disease and ADHD.

REFERENCES:
patent: WO 01/97786 (2001-12-01), None
patent: WO 03/043634 (2003-05-01), None
patent: WO 03/043636 (2003-05-01), None
patent: WO 03/045386 (2003-06-01), None
patent: WO 03/049741 (2003-06-01), None
patent: WO 03/053946 (2003-07-01), None
patent: WO 03/053954 (2003-07-01), None
patent: WO 03/053961 (2003-07-01), None
Buchwald et al., Org. Letters, 4, pp. 973-976 (2002).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiazolopyridine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiazolopyridine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiazolopyridine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3783631

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.